TNXP: Monkeypox Cases Push TNX-801 Into the Spotlight…
By David Bautz, PhD
NASDAQ:TNXP
READ THE FULL TNXP RESEARCH REPORT
XTMIF: XTM Grows 179% Through the Pandemic and Could Increase 300% in 2022
By Lisa Thompson
OTC:XTMIF
READ THE FULL XTMIF RESEARCH REPORT
UCASU: Pivoting for portfolio diversity
By Beth Senko, CFA
OTC:UCASU
READ THE FULL UCASU RESEARCH REPORT
MITC: MeaTech 3D announces 1st quarter results and provides updates on technology and business developments.
By Thomas Kerr, CFA
NASDAQ:MITC
READ THE FULL MITC RESEARCH REPORT
MNOV: Plans for Phase 2 Study of MN-001 (tipelukast) in NAFLD Patients with Type 2 Diabetes and Hypertriglyceridemia…
By David Bautz, PhD
NASDAQ:MNOV
READ THE FULL MNOV RESEARCH REPORT
RGC: Second investigational study of RGC-COV19™ replicates results of earlier trial in eliminating COVID-19 symptoms.
By Beth Senko, CFA
NASDAQ:RGC
RFHRF: Renforth Resources Continues to Advance Surimeau, an early stage polymetallic (Ni-Cu-Co-Zn) project; progress is being reported steadily on a monthly basis.
By Steven Ralston, CFA
OTC:RFHRF
READ THE FULL RFHRF RESEARCH REPORT
EPIX: Clinical Update on Phase 1 Monotherapy Trial of EPI-7386 Expected in 2Q22…
By David Bautz, PhD
NASDAQ:EPIX
READ THE FULL EPIX RESEARCH REPORT
CFRX: Results from Interim Futility Analysis in July 2022…
By David Bautz, PhD
NASDAQ:CFRX
READ THE FULL CFRX RESEARCH REPORT